CSPC Pharmaceutical Group Limited Share Price
Stocks
1093
HK1093012172
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Hong Kong S.E.
01:38:14 25/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 9.330 HKD | -0.11% |
|
+4.48% | +10.68% |
| Market Cap | 11TCr 1.36TCr 1.19TCr 1.13TCr 1.03TCr 1.92TCr 1,30100Cr 1.93TCr 13TCr 5.22TCr 66TCr 5.1TCr 4.99TCr 2,13700Cr | P/E 2026 * |
10.4x | P/E 2027 * | 15.6x |
|---|---|---|---|---|---|
| Enterprise Value | 9.53TCr 1.21TCr 1.07TCr 1.01TCr 917.52Cr 1.72TCr 1,16400Cr 1.73TCr 12TCr 4.67TCr 59TCr 4.56TCr 4.46TCr 1,91200Cr | EV / Sales 2026 * |
2.47x | EV / Sales 2027 * | 2.59x |
| Free-Float |
67.42% | Yield 2026 * |
4.77% | Yield 2027 * | 3.9% |
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 1093 | Delayed | |
Tradegate
| CVG | Real-time | |
|
OTC Markets
| CHJTF | Delayed | |
|
Deutsche Boerse AG
| CVG | Delayed | |
|
Börse Stuttgart
| CVG | Delayed | |
|
Boerse Muenchen
| CVG | Real-time |
| 1 day | -0.11% | ||
| 1 week | +4.48% | ||
| Current month | +0.97% | ||
| 1 month | -0.85% | ||
| 3 months | +40.30% | ||
| 6 months | +9.89% | ||
| Current year | +10.68% |
| 1 week | 9.02 |  | 9.8 |
| 1 month | 8.52 | | 9.8 |
| Current year | 6.53 | | 10.96 |
| 1 year | 6.53 | | 10.96 |
| 3 years | 4.27 | | 11.63 |
| 5 years | 4.27 | | 11.63 |
| 10 years | 3.87 | | 13.93 |
| Manager | Title | Age | Since |
|---|---|---|---|
George Cai
CEO | Chief Executive Officer | 46 | 19/12/2025 |
Qing Jie Wei
COO | Chief Operating Officer | 56 | 19/12/2025 |
Zhi Yong Qu
PRN | Corporate Officer/Principal | 44 | 01/07/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Dong Chen Cai
CHM | Chairman | 72 | 26/08/2011 |
Zhen Guo Wang
BRD | Director/Board Member | 56 | 20/01/2012 |
Bo Wang
BRD | Director/Board Member | 66 | 21/12/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 23/06/26 | Other | Director | -7,00,000 | 0.0061% | ||
| 29/05/26 | Other | Chairman | 94,02,000 | 0.0816% | ||
| 28/05/26 | Other | Chairman | 4,00,00,000 | 0.3471% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.11% | +4.48% | +0.32% | +63.40% | 1.36TCr | |
| +0.13% | +2.65% | +65.61% | +114.28% | 1,05500Cr | |
| +0.20% | +0.46% | +52.60% | +69.24% | 65TCr | |
| -0.29% | +0.14% | +20.96% | +70.93% | 47TCr | |
| -0.85% | +0.98% | +41.29% | +44.38% | 35TCr | |
| +0.71% | +4.08% | +22.24% | +29.51% | 27TCr | |
| +1.23% | +0.42% | +14.57% | +12.13% | 26TCr | |
| +2.11% | +7.51% | +52.89% | +55.37% | 22TCr | |
| +0.83% | +0.55% | +35.99% | +101.70% | 19TCr | |
| 0.00% | -10.14% | -29.94% | -60.30% | 17TCr | |
| Average | +0.31% | +1.11% | +27.65% | +50.06% | 36.52TCr | |
| Weighted average by Cap. | +0.02% | +1.33% | +41.38% | +67.81% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.85TCr 491.2Cr 431.03Cr 407.09Cr 370.98Cr 694.46Cr 47TCr 699.42Cr 4.87TCr 1.89TCr 24TCr 1.84TCr 1.8TCr 77TCr | 3.56TCr 454.28Cr 398.63Cr 376.49Cr 343.1Cr 642.26Cr 44TCr 646.85Cr 4.51TCr 1.74TCr 22TCr 1.71TCr 1.67TCr 71TCr |
| Net income | 1.02TCr 130.38Cr 114.41Cr 108.05Cr 98Cr 184.33Cr 12TCr 185.65Cr 1.29TCr 500.81Cr 6.38TCr 489.52Cr 478.93Cr 21TCr | 697.55Cr 89Cr 78Cr 74Cr 67Cr 125.72Cr 8.52TCr 126.62Cr 881.91Cr 341.58Cr 4.35TCr 333.88Cr 326.66Cr 14TCr |
| Net Debt | -1.12TCr -143Cr -125.48Cr -118.51Cr -108Cr -202.17Cr -14TCr -203.61Cr -1.42TCr -549.27Cr -7TCr -536.89Cr -525.28Cr -23TCr | -1.43TCr -182.11Cr -159.8Cr -150.93Cr -137.54Cr -257.47Cr -17TCr -259.31Cr -1.81TCr -699.53Cr -8.92TCr -683.76Cr -668.97Cr -29TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25/26/25 | HK$9.330 | -0.11% | 3,86,12,170 |
| 24/26/24 | HK$9.340 | -3.21% | 7,85,36,300 |
| 23/26/23 | HK$9.650 | -0.62% | 5,99,82,252 |
| 22/26/22 | HK$9.710 | +1.09% | 8,29,50,370 |
| 21/26/21 | HK$9.605 | +7.56% | 11,70,17,130 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 1093 Stock
Select your edition
All financial news and data tailored to specific country editions
